These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25869021)

  • 1. KLF15 in breast cancer: a novel tumor suppressor?
    Yoda T; McNamara KM; Miki Y; Onodera Y; Takagi K; Nakamura Y; Ishida T; Suzuki T; Ohuchi N; Sasano H
    Cell Oncol (Dordr); 2015 Jun; 38(3):227-35. PubMed ID: 25869021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KLF15 Inhibits Cell Proliferation in Gastric Cancer Cells via Up-Regulating CDKN1A/p21 and CDKN1C/p57 Expression.
    Sun C; Ma P; Wang Y; Liu W; Chen Q; Pan Y; Zhao C; Qian Y; Liu J; Li W; Shu Y
    Dig Dis Sci; 2017 Jun; 62(6):1518-1526. PubMed ID: 28421457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Rab23 on the proliferation and apoptosis in breast cancer.
    Liu Y; Zeng C; Bao N; Zhao J; Hu Y; Li C; Chi S
    Oncol Rep; 2015 Oct; 34(4):1835-44. PubMed ID: 26238143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.
    Gery S; Tanosaki S; Bose S; Bose N; Vadgama J; Koeffler HP
    Clin Cancer Res; 2005 May; 11(9):3184-90. PubMed ID: 15867211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-4262 Promotes Proliferation and Invasion of Human Breast Cancer Cells Through Directly Targeting KLF6 and KLF15.
    Wang K; Ren Y; Liu Y; Zhang J; He JJ
    Oncol Res; 2017 Jan; 25(2):277-283. PubMed ID: 27629257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kruppel-like factor-15 inhibits the proliferation of mesangial cells.
    Hong Q; Li C; Xie Y; Lv Y; Liu X; Shi S; Ding R; Zhang X; Zhang L; Liu S; Chen X
    Cell Physiol Biochem; 2012; 29(5-6):893-904. PubMed ID: 22613989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of GLTSCR2 expression is correlated with breast cancer progression.
    Moon A; Lim SJ; Jo YH; Lee S; Kim JY; Lee J; Park JH
    Pathol Res Pract; 2013 Nov; 209(11):700-4. PubMed ID: 24054033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent low expression of chromatin remodeling gene ARID1A in breast cancer and its clinical significance.
    Zhang X; Zhang Y; Yang Y; Niu M; Sun S; Ji H; Ma Y; Yao G; Jiang Y; Shan M; Zhang G; Pang D
    Cancer Epidemiol; 2012 Jun; 36(3):288-93. PubMed ID: 21889920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Male and female breast cancer--differences in DNA ploidy, p21 and p53 expression reinforce the possibility of distinct pathways of oncogenesis.
    André S; Pinto AE; Laranjeira C; Quaresma M; Soares J
    Pathobiology; 2007; 74(6):323-7. PubMed ID: 18087196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KLF15 suppresses tumor growth and metastasis in Triple-Negative Breast Cancer by downregulating CCL2 and CCL7.
    Kanyomse Q; Le X; Tang J; Dai F; Mobet Y; Chen C; Cheng Z; Deng C; Ning Y; Yu R; Zeng X; Xiang T
    Sci Rep; 2022 Nov; 12(1):19026. PubMed ID: 36347994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PI3K/AKT pathway-mediated regulation of p27(Kip1) is associated with cell cycle arrest and apoptosis in cervical cancer.
    Prasad SB; Yadav SS; Das M; Modi A; Kumari S; Pandey LK; Singh S; Pradhan S; Narayan G
    Cell Oncol (Dordr); 2015 Jun; 38(3):215-25. PubMed ID: 25821107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological significance of ARID1B in breast invasive ductal carcinoma.
    Shao F; Guo T; Chua PJ; Tang L; Thike AA; Tan PH; Bay BH; Baeg GH
    Histopathology; 2015 Nov; 67(5):709-18. PubMed ID: 25817822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. shRNA-mediated silencing of ZFX attenuated the proliferation of breast cancer cells.
    Yang H; Lu Y; Zheng Y; Yu X; Xia X; He X; Feng W; Xing L; Ling Z
    Cancer Chemother Pharmacol; 2014 Mar; 73(3):569-76. PubMed ID: 24448637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCL-6 oncoprotein in breast cancer: loss of expression in disease progression.
    Pinto AE; André S; Silva G; Vieira S; Santos AC; Dias S; Soares J
    Pathobiology; 2009; 76(5):235-42. PubMed ID: 19816083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement component 1, q subcomponent binding protein is a marker for proliferation in breast cancer.
    Scully OJ; Yu Y; Salim A; Thike AA; Yip GW; Baeg GH; Tan PH; Matsumoto K; Bay BH
    Exp Biol Med (Maywood); 2015 Jul; 240(7):846-53. PubMed ID: 25573962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
    Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
    Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The carboxy-terminal domain of connexin 43 (CT-Cx43) modulates the expression of p53 by altering miR-125b expression in low-grade human breast cancers.
    Maqbool R; Rashid R; Ismail R; Niaz S; Chowdri NA; Hussain MU
    Cell Oncol (Dordr); 2015 Dec; 38(6):443-51. PubMed ID: 26335100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear expression of KLF6 tumor suppressor factor is highly associated with overexpression of ERBB2 oncoprotein in ductal breast carcinomas.
    Gehrau RC; D'Astolfo DS; Dumur CI; Bocco JL; Koritschoner NP
    PLoS One; 2010 Jan; 5(1):e8929. PubMed ID: 20126619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p14ARF expression in invasive breast cancers and ductal carcinoma in situ--relationships to p53 and Hdm2.
    Vestey SB; Sen C; Calder CJ; Perks CM; Pignatelli M; Winters ZE
    Breast Cancer Res; 2004; 6(5):R571-85. PubMed ID: 15318938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma.
    Suzuki T; Nakata T; Miki Y; Kaneko C; Moriya T; Ishida T; Akinaga S; Hirakawa H; Kimura M; Sasano H
    Cancer Res; 2003 Jun; 63(11):2762-70. PubMed ID: 12782580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.